Rick E. Winningham - May 20, 2021 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
Chief Executive Officer, Director
Signature
Brett A. Grimaud, Attorney-in-Fact.
Stock symbol
TBPH
Transactions as of
May 20, 2021
Transactions value $
-$202,991
Form type
4
Date filed
5/24/2021, 06:19 PM
Next filing
Aug 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Tax liability -$203K -11.4K -0.85% $17.80 1.32M May 20, 2021 Direct F1
holding TBPH Ordinary Shares 92.6K May 20, 2021 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,401 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 14, 2021.